Lecithin Cholesterol Acyltransferase Deficiency
Lecithin Cholesterol Acyltransferase Deficiency
Explore linked clinical trials. Standard reference: MESH:M00122772 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lecithin Cholesterol Acyltransferase Deficiency, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, hereditary disease, hypoalphalipoproteinemia, hypolipoproteinemia, inborn errors of metabolism, metabolic disease | Recruiting | Phase 1 | 2026-07-24 | NCT07629999 | |
| LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lecithin Cholesterol Acyltransferase Deficiency, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, cardiovascular disorder, hereditary disease, hypoalphalipoproteinemia, hypolipoproteinemia, inborn errors of metabolism, kidney disorder, metabolic disease, urinary system disorder | Recruiting | Not stated | 2026-05-06 | NCT06217588 |